Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors

Nuclear Medicine and Biology

Volumn 23, Issue 6, 1996, Pages 793-805

  Yang, Zhi Ying ^a   Perry, Bruce ^b,c   Mukherjee, Jogeshwar ^a,b  

^a Franklin McLean Memorial Research Institute   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

fluorine 18; PET; radiotracers; substituted benzazepines

Indexed keywords

5 (3 AMINOPHENYL) 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPIN 7 OL; BENZAZEPINE DERIVATIVE; DOPAMINE RECEPTOR; FLUORINE 18;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MONKEY; POSITRON EMISSION TOMOGRAPHY; RAT;

EID: 0030220487     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00076-5     Document Type: Article

References (57)

1. 1 dopamine receptor by photoaffinity crosslinking. Mol. Pharmacol. 31, 129-134.
2. 1 receptor antagonists. Eur. J. Pharmacol. 219, 45-52.
3. 3. Bakthavachalam N., Baindur N., Madras B. K. and Neumeyer J. L. (1991) Fluorescent probes for dopamine receptors: Synthesis and characterization of fluorescein and 7-nitrobenz-2-oxa-1,3diazol-4-yl conjugates of D-1 and D-2 receptor ligands. J. Med. Chem. 34, 3235-3241.
4. 4. Barnett A., Iorio L. C. and Billard W. (1986) In: Modulation of Central and Peripheral Neurotransmitter Function (Edited by Biggio G., Spano P. F. and Gessa G. L.), pp. 15-25. Liviana Press, Padova, Italy.
5. 5. Barton A. C., Kang H. C., Rinaudo M. S., Monsma F. J., Stewart-Fram R. M., Macinko J. A., Haugland R. P., Ariano M. A. and Sibley D. R. (1991) Multiple fluorescent ligands for dopamine receptors: I. Pharmacological characterization and receptor selectivity. Brain Res. 547, 199-207.
6. 6. Berger J. G., Chang W. K., Clader J. W., Hou D., Chipkin R. E. and McPhail A. T. (1989) Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D-1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol. J. Med. Chem. 32, 1913-1921.
7. 7. Billard W., Ruperto V., Crosby G., Iorio L. C. and Barnett A. (1984) Characterization of the binding of [H-3]SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci. 35, 1885-1893.
8. 1 dopamine receptor. J. Neurochem. 58, 227-236.
9. 9. Brewster W. K., Nichols D. E., Watts V. J., Riggs R. M., Mottola D. and Mailman R. B. (1995) Evaluation of cis-and trans-9-and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]-phenanthridines as structurally rigid, selective D1 dopamine receptor ligands. J. Med. Chem. 38, 318-327.
10. 10. Chipkin R. E. (1990) D1 antagonist in clinical trial. Trends Pharm. Sci. 11, 185.
11. 11. Chipkin R. E., Iorio L. C., Coffin V. L., McQuade R. D., Berger J. G. and Barnett A. (1988) Pharmacological profile of SCH 39166: A dopamine D-1 selective benzonaphthazepine with potential antipsychotic activity. J. Pharmacol. Exp. Ther. 247, 1093.
12. 12. Chumpradit S., Kung M-P., Billings J. J. and Kung H. F. (1991) Synthesis and resolution of (±)-7-chloro-8-hydroxy-1-(3′-iodophenyl)-3-methyl-2,3,4,5-tetrahtdro-1H-3-benzazepine (TISCH): A high affinity and selective iodinated ligand for CNS D1 dopamine receptor. J. Med. Chem. 34, 877-883.
13. 1 dopamine receptor ligands. J. Label. Campd. Radiopharm. 30, 347.
14. 14. Civelli O., Bunzow J. R. and Grandy D. K. (1993) Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 32, 281-307.
15. 15. Clark D. and White F. J. (1987) Review: D-1 dopamine receptor - The search for a function: A critical evaluation of the D-1/D-2 dopamine receptor classification and its functional implications. Synapse 1, 347-388.
16. 16. Daly S. A. and Waddington J. L. (1992) Two directions of dopamine D-1/D-2 receptor interaction in studies of behavioral regulation: A finding generic to four new selective dopamine D-1 receptor antagonists. Eur. J. Pharmacol. 213, 251-258.
17. 17. Dawson T. M., Gehlert D. R., McCabe R. T., Barnett A. and Wamsley J. K. (1986) D-1 dopamine receptors in the rat brain: A quantitative autoradiography analysis. J. Neurosci. 6, 2352-2365.
18. 18F-2-fluoro-2-deoxy-D-glucose. Appl. Radiat. Isot. 37, 397-401.
19. 19. DeJesus O. T., Van Moffaert G. J. C. and Friedman A. M. (1986) Synthesis of [C-11]SCH 23390 for dopamine D-1 receptor studies. Appl. Radiat. Isot. 38, 345-348.
20. 20. DeNinno M. P., Schoenleber R., Ferner R. J., Lijewski L., Asin K. E., Britton D. R., Mackenzie R. and Kebabian J. W. (1991) Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl) 3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: Characterization of an auxiliary binding region in the D1 receptor. J. Med. Chem. 34, 2561-2569.
21. 21. Ding Y-S., Shiue C-Y., Fowler J. S., Wolf A. P. and Plenevaux A. (1990) No carrier added (NCA) aryl [F-18]fluorides via the nucleophilic aromatic substitution of electron-rich aromatic rings. J. Fluorine Chem. 48, 189.
22. 22. Ellenbrook B. A., Willeman A. P. M. and Cools A. R. (1989) Are antagonists of dopamine D-1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? Neuropharmacology 2, 191-199.
23. 23. Farde L., Halldin C., Stone-Elander S. and Sedvall G. (1987) PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology 92, 278-284.
24. 1 dopamine receptor ligand, and preliminary PET investigations. Appl. Radiat. Isot. 42, 451-455.
25. 25. Halldin C., Foged C., Farde L., Karlsson P., Hansen K., Gronwald F., Swahn CG., Hall H. and Sedvall G. (1993) [C-11]NNC 687 and [C-11]NNC 756, dopamine D-1 receptor ligands: Preparation, autoradiography and PET investigation in monkey, Nucl. Med. Biol. 20, 945-953.
26. 26. Hyttel J. (1983) SCH 23390 - The first selective dopamine D-1 antagonist. Eur. J. Pharmaccol. 91, 153-154.
27. 27. Iorio L. C., Barnett A., Billard W. and Gold E. H. (1986) In: Neurobiology of Central D1-Dopamine Receptors. (Edited by Breese G. R. and Creese I.), pp. 1-14. Plenum Press, New York.
28. 28. Kaiser C. and Jain T. (1985) Dopamine receptors: Functions, subtypes and emerging concepts. Med. Res. Rev. 5, 145-229.
29. 29. Karlsson P., Farde L., Halldin C., Swahn C-G., Sedvall G., Foged C., Hansen K. T. and Skrumsager B. (1993) PET examination of [C-11]NNC 687 and [C-11]NNC 756 as new radioligands for the D-1 dopamine receptor. Psychopharmacology 113, 149-156.
30. 11C]A-69024: A potent and selective non-benzazepine radiotracer for in vivo studies of dopamine D1 receptors. Nucl. Med. Biol. 22, 221-226.
31. 31. Kebabian J. and Calne D. B. (1979) Multiple receptors for dopamine. Nature 277, 93-96.
32. 32. Laihinen A. O., Rinne J. O., Ruottinen H. M., Nagren K. A., Lehikoinen P. K., Oikonen V. J., Ruotsalainen U. H. and Rinne U.K. (1994) PET studies on dopamine D-1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756. J. Nucl. Med. 35, 1916-1920.
33. 33. Lannoye G. S., Moerlein S. M., Parkinson D. and Welch M. J. (1990) N-fluoroalkylated and N-alkyhited analogues of the dopammergic D-2 receptor antagonist raclopride. J. Med. Chem. 33, 2430-2437.
34. 34. La Hoste G. J. and Marshall J. F. (1992) Dopamine supersensitivity and D-1/D-2 synergism are unrelated to changes in striatal receptor density. Synapse 12, 14-26.
35. 35. Love P., Cohen R. B. and Taft R. W. (1968) Polar substituent effects in gas-phase Lewis acid-base equilibria: I. Intrinsic basicity of amines. J. Am. Chem. Soc. 90, 2455.
36. 36. Mach R. H., Elder S. T., Morton T. E., Nowak P. A., Evora P. H., Scripko J. G., Luedke R. R., Unsworth C. D., Filtz T., Rao A. V., Molinoff P. B. and Ehrenkaufer R. L. E. (1993) The use of [F-18]4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis: Model alkylation studies and its application in the design of dopamine D-1 and D-2 receptor-based imaging agents. Nucl. Med. Biol. 20, 777-794.
37. 37. Madras B. K., Canfield D. R., Pfaelzer C., Vittimberga F. J., Difiglia M., Aronin N., Bakthachalam V., Baindur N. and Neumeyer J. (1990) Fluorescent and biotin probes for dopamine receptors: D-1 and D-2 receptor affinity and selectivity. Mol. Pharmacol. 37, 833-839.
38. 1 receptors in schizophrenia. Eur. J. Pharmacol. 233, 175-176.
39. 39. McHugh D. and Coffin V. (1991) The reversal of extrapyramidal side effects with SCH 39166, a dopamine D1 receptor antagonist. Eur. J. Pharmacol. 202, 133-134.
40. 40. Michaelides M. R., Schoenleber R., Thomas S., Yamamoto D. M., Britton D. R., Mackenzie R. and Kebabian J. W. (1991) Synthesis and pharmacological evaluation of 1-(aminomethyl)-3,4-dihydro-5-hydroxy-1H-2-benzopyrans as dopamine D1 selective ligands. J. Med. Chem. 34, 2946-2953.
41. 41. Minor D. L., Wyrick S. D., Charifson P. S., Watts V. J., Nichols D. E. and Mailman R. B. (1994) Synthesis and molecular modeling of 1-phe nyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists. J. Med. Chem. 37, 4317-4328.
42. 42. Moerlein S. M., Lannoye O.S. and Welch M. J. (1989) No carrier added synthesis of N-[F-18]fluoroethyl SCH 23390: A potential agent for mapping cerebral dopamine D-1 receptors. J. Nucl. Med. 30, 931.
43. 43. Mukherjee J. (1990) Use of diethylaminosulfur trifluoride in an efficient synthesis of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(3-fluoropropyl)-2-methoxybenzamide. J. Fluorine Chem. 49, 151-154.
44. 44. Mukherjee J., Yang Z. Y. and Perry B.D. (1993) Fluorine-18-labelled substituted benzazepines as potential radiotracers for imaging dopamine D1 receptors by positron emission tomography. Eur. J. Pharmacol. 243, 287-290.
45. 45. Munson P. J. and Rodbard D. (1980) LIGAND: A versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107, 220-239.
46. 46. Neumeyer J. L., Baindur N., Yuan J., Booth G., Seeman P. and Niznik H. B. (1990) Development of a high affinity and stereoselective photoaffinity label for the D-1 dopamine receptor: Synthesis and resolution. J. Med. Chem. 33, 521-526.
47. 47. O'Boyle K. M. and Waddington J. L. (1987) [3H]SCH 23390 binding to human putamen D-1 dopamine receptors: Stereochemical and structure-affinity relationships among 1-phenyl-1H-3-benzazepine derivatives as a guide to D-1 receptor topography. J. Neurochem. 48, 1039-1042.
48. 48. Rafizadeh K. and Yates K. (1985) One-pot synthesis of nitrostyrene oxides. OPP1 Briefs 17, 140-142.
49. 49. Sawaguchi T. and Goldman-Rakic P. S. (1991) D1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science 251, 947-950.
50. 50. Seeman P., Niznik H. B., Guan H.-C., Booth G. and Ulpian C. (1989) Link between D-1 and D-2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc. Natl. Acad. Sci. USA 86, 10156-10160.
51. 51. Shah J. H., Izenwasser S., Geter-Douglass B., Witkin J. M. and Newman A. H. (1995) (±)-(N-Alkylamino)benzazepine analogs: Novel dopamine D1 receptor antagonists. J. Med. Chem. 38, 4284-4293.
52. 52. Snyder S. E., Aviles-Garay F. A., Chakraborti R., Nichols D. E., Watts V. J. and Mailman R. B. (1995) Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H-benzo[6,7]cyclohepta[1,2,3-ef] [3]benazepine, 6,7-dihydroxy-1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd] azepme, and 10-(aminomethyl)-9,10-dihydro 1,2-dihydroxyanthracene as conformationally restricted analogs of β-phenyldopamine. J. Med. Chem. 38, 2395-2409.
53. 53. Sugamori K. S., Demchyshyn L. L., Chung M. and Niznik H. B. (1994) D1A, D1B, and D1C dopamine receptors from Xenopus laevis. Proc. Natl. Acad. Sci. 91, 10536-10540.
54. 54. Suhara T., Nakayama K., lnoue O., Fukuda H., Shimizu M., Mori A. and Tateno Y. (1992) D1 dopamine receptor binding in mood disorders measured by positron emission tomography, Psychopharmacology 106, 14-18.
55. 55. Sunahara R. K., Guan H. C-, O'Dowd B. F., Seeman P., Laurier L. G., Ng G., George S. R., Torchia J., Van Tol H. H. M. and Niznik H. B. (1991) Cloning of the gene for a human dopamine D-5 receptor with higher affinity for dopamine than D-1. Nature 350, 614-619.
56. 56. Teng R-R., Bai L-Q., Shiue C-Y., Dewey S. L., Arnett C. D., Wolf A. P. and Hitzemann R. J. (1990) The utility of 1-[F-18]fluoro-3-iodopropane for the synthesis of certain dopamine and benzodiazepine receptor radioligands. Nucl. Med. Biol. 17, 811-813.
57. 57. Ter-Pogossian M. M., Ficke D. C., Hood J. T., Yamamoto M. and Mullani N. A. (1982) PETT VI: A positron emission tomograph utilizing cesium fluoride scintillation detectors. J. Comput. Assist. Tomogr. 6, 125-133.